Study of BGB-11417 in Patients with Mature B Cell Malignancies
BGB-11417-101
Phase 1 other active
Quick answer
Study of BGB-11417 in Patients with Mature B Cell Malignancies for Mature B Cell Malignancies is a Phase 1 program (other) at Beone Medicines Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Beone Medicines Ireland Limited
- Indication
- Mature B Cell Malignancies
- Phase
- Phase 1
- Modality
- other
- Status
- active